IGBMC
Maulik Nariya is a Postdoctoral Research Fellow at IGBMC since September 2022, focusing on biophysical modeling of gene regulation. Prior to this role, Maulik served as a Postdoctoral Research Fellow at Harvard Medical School from August 2018 to August 2022, where research centered on cancer pharmacology, particularly analyzing multi-omics datasets to understand cancer cell responses to therapies. Maulik's academic experience includes a position as a Graduate Research Assistant at The University of Kansas from August 2012 to August 2016, working on an FDA-funded project assessing biosimilar drugs, and as a Graduate Teaching Assistant, teaching general physics laboratory courses. Earlier research experience includes serving as a Junior Research Fellow at the Tata Institute of Fundamental Research in Mumbai from August 2009 to July 2012, focusing on neutrino oscillations and performing simulations and data analysis. Maulik holds a PhD in Physics from The University of Kansas, as well as a Master's degree from Savitribai Phule Pune University and a Bachelor's degree from St. Xavier's College.
This person is not in any teams
IGBMC
Created in 1994 by Pierre Chambon, one of the most important figures in biomedical research, the IGBMC is now one of the main European research centres in this domain. In France, it is the largest research unit, involving the CNRS, Inserm and the University of Strasbourg. In addition to its four scientific programs, the IGBMC has developed advanced scientific services and technological platforms for internal use, but also open to the wider scientific community. The Institute aims to develop interdisciplinary research at the interface of biology, biochemistry, physics and medicine, but also to attract students from around the world by offering very high-level education in the field of biomedical sciences. The IGBMC campus is located on the "Parc d'Innovation d'Illkirch" in the Strasbourg suburbs, which represents an exceptional scientific, academic and industrial environment and largely favours collaborations and technology transfer.